P1EA34 Stock Overview
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
+ 2 more risks
Healthpeak Properties, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$93.50 |
52 Week High | US$105.40 |
52 Week Low | US$77.28 |
Beta | 1.02 |
1 Month Change | 6.99% |
3 Month Change | -0.17% |
1 Year Change | -12.87% |
3 Year Change | -48.63% |
5 Year Change | n/a |
Change since IPO | -39.60% |
Recent News & Updates
Recent updates
Shareholder Returns
P1EA34 | BR Health Care REITs | BR Market | |
---|---|---|---|
7D | 0% | 0.8% | 0.5% |
1Y | -12.9% | 1.0% | 16.7% |
Return vs Industry: P1EA34 underperformed the BR Health Care REITs industry which returned 2.3% over the past year.
Return vs Market: P1EA34 underperformed the BR Market which returned 16.7% over the past year.
Price Volatility
P1EA34 volatility | |
---|---|
P1EA34 Average Weekly Movement | n/a |
Health Care REITs Industry Average Movement | 3.2% |
Market Average Movement | 4.7% |
10% most volatile stocks in BR Market | 8.6% |
10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: P1EA34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine P1EA34's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 193 | Scott Brinker | www.healthpeak.com |
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Healthpeak Properties, Inc. Fundamentals Summary
P1EA34 fundamental statistics | |
---|---|
Market cap | R$68.67b |
Earnings (TTM) | R$1.00b |
Revenue (TTM) | R$11.74b |
68.8x
P/E Ratio5.9x
P/S RatioIs P1EA34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
P1EA34 income statement (TTM) | |
---|---|
Revenue | US$2.26b |
Cost of Revenue | US$1.02b |
Gross Profit | US$1.24b |
Other Expenses | US$1.05b |
Earnings | US$193.06m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.27 |
Gross Margin | 54.98% |
Net Profit Margin | 8.54% |
Debt/Equity Ratio | 91.2% |
How did P1EA34 perform over the long term?
See historical performance and comparison